Tandem Diabetes Care Inc (NASDAQ:TNDM) has a beta value of 1.49 and has seen 0.55 million shares traded in the recent trading session. The company, currently valued at $1.15B, closed the recent trade at $17.34 per share which meant it gained $0.99 on the day or 6.06% during that session. The TNDM stock price is -209.63% off its 52-week high price of $53.69 and 9.17% above the 52-week low of $15.75. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.69 million shares traded. The 3-month trading volume is 1.64 million shares.
The consensus among analysts is that Tandem Diabetes Care Inc (TNDM) is Buy stock at the moment, with a recommendation rating of 2.04. 1 analysts rate the stock as a Sell, while 0 rate it as Overweight. 1 out of 10 have rated it as a Hold, with 8 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -0.61.
Tandem Diabetes Care Inc (NASDAQ:TNDM) trade information
Sporting 6.06% in the green today, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the TNDM stock price touched $17.34 or saw a rise of 2.14%. Year-to-date, Tandem Diabetes Care Inc shares have moved -51.86%, while the 5-day performance has seen it change -2.09%. Over the past 30 days, the shares of Tandem Diabetes Care Inc (NASDAQ:TNDM) have changed -15.91%. Short interest in the company has seen 7.27 million shares shorted with days to cover at 3.89.
Wall Street analysts have a consensus price target for the stock at $31, which means that the shares’ value could jump 44.06% from the levels at last check today.. The projected low price target is $22.0 while the price target rests at a high of $53.0. In that case, then, we find that the latest price level in today’s session is -205.65% off the targeted high while a plunge would see the stock gain -26.87% from the levels at last check today..
Tandem Diabetes Care Inc (TNDM) estimates and forecasts
The company’s shares have lost -50.93% over the past 6 months. Revenue growth from the last financial year stood is estimated to be 6.23%.
19 analysts offering their estimates for the company have set an average revenue estimate of 220.22M for the current quarter. 19 have an estimated revenue figure of 244.82M for the next ending quarter. Year-ago sales stood 191.67M and 221.91M respectively for this quarter and the next, and analysts expect sales will grow by 14.89% for the current quarter and 6.23% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -28.23% over the past 5 years. Earnings growth for 2025 is a modest 13.32% while over the next 5 years, the company’s earnings are expected to increase by 45.78%.
TNDM Dividends
Tandem Diabetes Care Inc is expected to release its next earnings report on 2025-Feb-25 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Tandem Diabetes Care Inc (NASDAQ:TNDM)’s Major holders
Insiders own 0.83% of the company shares, while shares held by institutions stand at 108.94% with a share float percentage of 109.86%. Investors are also buoyed by the number of investors in a company, with Tandem Diabetes Care Inc having a total of 429.0 institutions that hold shares in the company. The top two institutional holders are BLACKROCK INC. with over 11.12 million shares worth more than $448.14 million. As of 2024-06-30, BLACKROCK INC. held 17.1137% of shares outstanding.
The other major institutional holder is VANGUARD GROUP INC, with the holding of over 7.38 million shares as of 2024-06-30. The firm’s total holdings are worth over $297.26 million and represent 11.3518% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are iShares Trust-iShares Core S&P Small-Cap ETF and VANGUARD EXPLORER FUND . As of Mar 31, 2025 , the former fund manager holds about 6.10% shares in the company for having 4.06 shares of worth $69.11 million while later fund manager owns 2.07 shares of worth $35.23 million as of Jan 31, 2025 , which makes it owner of about 3.11% of company’s outstanding stock.
